Glucon

Experience seamless, precise, and real-time glucose monitoring with top-notch Photoacoustic technology in a compact, wearable device.

General Information
Company Name
Glucon
Founded Year
2000
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
-
Funding Stage
Series D
Social Media

Glucon - Company Profile

Glucon is a development stage company with a focus on creating glucose monitoring devices for the diabetes market. The company's slogan "Experience seamless, precise, and real-time glucose monitoring with top-notch Photoacoustic technology in a compact, wearable device" encapsulates its mission. Utilizing a novel Photoacoustic technology, which is protected by several granted and pending patents, the devices are designed to be small and conveniently wearable, offering continuous, accurate, and real-time glucose monitoring for both clinical and personal use. Glucon has demonstrated the superior performance of Photoacoustics compared to optics alone, providing direct blood glucose measurements from inside blood vessels, enhancing both the specificity and sensitivity of glucose measurement. The company's desktop prototype device is currently undergoing extensive clinical trials. In terms of funding, Glucon received its last investment in the form of a Series D investment on 22 January 2007. The investors involved in this round included 3i Group, Giza Venture Capital, Quest Capital, Sequel Venture Partners, Covera Ventures, Ascend Technology Ventures, and MKI. With its innovative approach to glucose monitoring and ongoing clinical trials, Glucon presents an intriguing investment opportunity in the healthcare technology space.

Taxonomy: glucose monitoring, Photoacoustic technology, diabetes market, wearable devices, clinical trials, optical and sound-based methods, patents, real-time monitoring, specificity, sensitivity, blood glucose measurements, novel technology, compact device, precision, continuous monitoring

Funding Rounds & Investors of Glucon (3)

View All
Funding Stage Amount No. Investors Investors Date
Series D Unknown 7 MKI 22 Jan 2007
Series C $12.63M 1 10 Feb 2005
Series A $13.00M 2 Innomed Ventures 07 Jan 2004

Latest News of Glucon

View All

No recent news or press coverage available for Glucon.

Similar Companies to Glucon

View All
Intuity Medical, Inc. - Similar company to Glucon
Intuity Medical, Inc. Making life with diabetes easier
GWave - Similar company to Glucon
GWave Developing a non-invasive technology that continuously measures blood glucose levels using RF waves.
AgaMatrix - Similar company to Glucon
AgaMatrix We design, develop, and manufacture world-class products for diabetes care.
OptiScan Biomedical Corporation - Similar company to Glucon
OptiScan Biomedical Corporation Precision Glucose Monitoring for ICU and CCU Care